Penumbra (PEN) Interest & Investment Income (2014 - 2026)
Penumbra's (PEN) quarterly Interest & Investment Income came in at $5.1 million in Q2 2026, up 14.86% year-over-year from $4.5 million in Q2 2025, and up 49.04% quarter-over-quarter from $3.5 million in Q1 2026.
Analysis
Penumbra (PEN) Interest & Investment Income (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Interest & Investment Income for 13 consecutive years, with $5.1 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Interest & Investment Income rose 14.86% year-over-year to $5.1 million in Q2 2026; TTM through Jun 2026 was $16.6 million, a 6.97% increase from a year earlier, with the FY2022 full-year figure at $137000.0, down 85.39% from the prior year.
- Interest & Investment Income was $5.1 million for Q2 2026 at Penumbra, up from $3.5 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $5.1 million in Q2 2026 and troughed at -$72000.0 in Q2 2022.
- A 5-year average of $2.2 million and a median of $2.5 million in 2024 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income plunged 131.16% in 2022 and surged 2387.5% in 2023, its largest moves.
- Over 5 years, Interest & Investment Income stood at $299000.0 in 2022, then soared by 127.09% to $679000.0 in 2023, then soared by 550.07% to $4.4 million in 2024, then slipped by 21.0% to $3.5 million in 2025, then surged by 47.63% to $5.1 million in 2026.
- The last three Interest & Investment Income figures came in at $5.1 million (Q2 2026), $3.5 million (Q1 2026), and $3.5 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 178.25 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Intuitive Surgical | 124.18 Bn | 118.97 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.18 Bn | 109.36 Bn | 6.34 Bn | - |
| 4 | Stryker | 104.54 Bn | 101.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.34 Bn | 65.80 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.64 Bn | 45.39 Bn | 1.35 Bn | 30.00 Mn |
| 7 | Alcon | 33.93 Bn | 32.47 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.20 Bn | 30.25 Bn | 830.00 Mn | - |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn | - |
| 10 | Penumbra | 12.58 Bn | 11.92 Bn | 264.94 Mn | 5.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.15 Mn |
| Mar 31, 2026 | 3.45 Mn |
| Sep 30, 2025 | 3.49 Mn |
| Jun 30, 2025 | 4.48 Mn |
| Mar 31, 2025 | 3.51 Mn |
| Sep 30, 2024 | 4.41 Mn |
| Jun 30, 2024 | 3.09 Mn |
| Mar 31, 2024 | 2.53 Mn |
| Sep 30, 2023 | 679,000.00 |
| Jun 30, 2023 | 1.65 Mn |
| Mar 31, 2023 | 644,000.00 |
| Dec 31, 2022 | 299,000.00 |
| Sep 30, 2022 | -43,000.00 |
| Jun 30, 2022 | -72,000.00 |
| Mar 31, 2022 | -47,000.00 |
| Dec 31, 2021 | 21,000.00 |
| Sep 30, 2021 | 138,000.00 |
| Jun 30, 2021 | 299,000.00 |
| Mar 31, 2021 | 480,000.00 |
| Dec 31, 2020 | 447,000.00 |